Literature DB >> 21689664

Conserved C-terminal charge exerts a profound influence on the aggregation rate of α-synuclein.

Katerina Levitan1, David Chereau, Samuel I A Cohen, Tuomas P J Knowles, Christopher M Dobson, Anthony L Fink, John P Anderson, Jason M Goldstein, Glenn L Millhauser.   

Abstract

α-Synuclein (α-syn) is the major component of filamentous Lewy bodies found in the brains of patients diagnosed with Parkinson's disease (PD). Recent studies demonstrate that, in addition to the wild-type sequence, α-syn is found in several modified forms, including truncated and phosphorylated species. Although the mechanism by which the neuronal loss in PD occurs is unknown, aggregation and fibril formation of α-syn are considered to be key pathological features. In this study, we analyze the rates of fibril formation and the monomer-fibril equilibrium for eight disease-associated truncated and phosphorylated α-syn variants. Comparison of the relative rates of aggregation reveals a strong monotonic relationship between the C-terminal charge of α-syn and the lag time prior to the observation of fibril formation, with truncated species exhibiting the fastest aggregation rates. Moreover, we find that a decrease in C-terminal charge shifts the equilibrium to favor the fibrillar species. An analysis of these findings in the context of linear growth theories suggests that the loss of the charge-mediated stabilization of the soluble state is responsible for the enhanced aggregation rate and increased extent of fibril fraction. Therefore, C-terminal charge is kinetically and thermodynamically protective against α-syn polymerization and may provide a target for the treatment of PD.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21689664      PMCID: PMC3143250          DOI: 10.1016/j.jmb.2011.05.046

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  28 in total

1.  Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro.

Authors:  Wolfgang Hoyer; Dmitry Cherny; Vinod Subramaniam; Thomas M Jovin
Journal:  Biochemistry       Date:  2004-12-28       Impact factor: 3.162

Review 2.  Interaction between alpha-synuclein and metal ions, still looking for a role in the pathogenesis of Parkinson's disease.

Authors:  Marco Bisaglia; Isabella Tessari; Stefano Mammi; Luigi Bubacco
Journal:  Neuromolecular Med       Date:  2009       Impact factor: 3.843

3.  Methionine oxidation stabilizes non-toxic oligomers of alpha-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions.

Authors:  Wenbo Zhou; Chunmei Long; Stephen H Reaney; Donato A Di Monte; Anthony L Fink; Vladimir N Uversky
Journal:  Biochim Biophys Acta       Date:  2009-12-21

4.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

5.  Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations.

Authors:  Wenxue Li; Neva West; Emanuela Colla; Olga Pletnikova; Juan C Troncoso; Laura Marsh; Ted M Dawson; Pekka Jäkälä; Tobias Hartmann; Donald L Price; Michael K Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

6.  Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes.

Authors:  W S Davidson; A Jonas; D F Clayton; J M George
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

7.  Role of alpha-synuclein carboxy-terminus on fibril formation in vitro.

Authors:  Ian V J Murray; Benoit I Giasson; Shawn M Quinn; Vishwanath Koppaka; Paul H Axelsen; Harry Ischiropoulos; John Q Trojanowski; Virginia M-Y Lee
Journal:  Biochemistry       Date:  2003-07-22       Impact factor: 3.162

8.  Kinetics of sickle hemoglobin polymerization. II. A double nucleation mechanism.

Authors:  F A Ferrone; J Hofrichter; W A Eaton
Journal:  J Mol Biol       Date:  1985-06-25       Impact factor: 5.469

9.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

Authors:  K Uéda; H Fukushima; E Masliah; Y Xia; A Iwai; M Yoshimoto; D A Otero; J Kondo; Y Ihara; T Saitoh
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

10.  Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease.

Authors:  Nikolaus R McFarland; Zhanyun Fan; Kui Xu; Michael A Schwarzschild; Mel B Feany; Bradley T Hyman; Pamela J McLean
Journal:  J Neuropathol Exp Neurol       Date:  2009-05       Impact factor: 3.685

View more
  46 in total

1.  Hydration dynamics as an intrinsic ruler for refining protein structure at lipid membrane interfaces.

Authors:  Chi-Yuan Cheng; Jobin Varkey; Mark R Ambroso; Ralf Langen; Songi Han
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

Review 2.  Membranes as modulators of amyloid protein misfolding and target of toxicity.

Authors:  Anoop Rawat; Ralf Langen; Jobin Varkey
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-25       Impact factor: 3.747

3.  Glycosaminoglycans have variable effects on α-synuclein aggregation and differentially affect the activities of the resulting amyloid fibrils.

Authors:  Surabhi Mehra; Dhiman Ghosh; Rakesh Kumar; Mrityunjoy Mondal; Laxmikant G Gadhe; Subhadeep Das; Arunagiri Anoop; Narendra N Jha; Reeba S Jacob; Debdeep Chatterjee; Soumik Ray; Nitu Singh; Ashutosh Kumar; Samir K Maji
Journal:  J Biol Chem       Date:  2018-06-29       Impact factor: 5.157

4.  Cysteine cathepsins are essential in lysosomal degradation of α-synuclein.

Authors:  Ryan P McGlinchey; Jennifer C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

5.  Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.

Authors:  Zachary A Sorrentino; Niran Vijayaraghavan; Kimberly-Marie Gorion; Cara J Riffe; Kevin H Strang; Jason Caldwell; Benoit I Giasson
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

6.  Systematic mutagenesis of α-synuclein reveals distinct sequence requirements for physiological and pathological activities.

Authors:  Jacqueline Burré; Manu Sharma; Thomas C Südhof
Journal:  J Neurosci       Date:  2012-10-24       Impact factor: 6.167

7.  Membrane-Bound Alpha Synuclein Clusters Induce Impaired Lipid Diffusion and Increased Lipid Packing.

Authors:  Aditya Iyer; Nathalie Schilderink; Mireille M A E Claessens; Vinod Subramaniam
Journal:  Biophys J       Date:  2016-12-06       Impact factor: 4.033

8.  The effect of truncation on prion-like properties of α-synuclein.

Authors:  Makoto Terada; Genjiro Suzuki; Takashi Nonaka; Fuyuki Kametani; Akira Tamaoka; Masato Hasegawa
Journal:  J Biol Chem       Date:  2018-07-20       Impact factor: 5.157

9.  Structural basis of the interplay between α-synuclein and Tau in regulating pathological amyloid aggregation.

Authors:  Jinxia Lu; Shengnan Zhang; Xiaojuan Ma; Chunyu Jia; Zhenying Liu; Chengan Huang; Cong Liu; Dan Li
Journal:  J Biol Chem       Date:  2020-04-13       Impact factor: 5.157

10.  Coordination of copper to the membrane-bound form of α-synuclein.

Authors:  Christopher G Dudzik; Eric D Walter; Benjamin S Abrams; Melissa S Jurica; Glenn L Millhauser
Journal:  Biochemistry       Date:  2012-12-26       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.